Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06613347 · ClinicalTrials.gov registry record · NA
Clinical Study to Assess the Efficacy of Professional Tooth Whitening Maintenance System
A NA study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
NCT06613347: Completed NA study, sponsored by Colgate Palmolive.
NCT06613347 is a NA study that has completed, run by Colgate Palmolive. The registered enrollment target is 93 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06613347, a NA study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
Study Summary
Clinical study to assess the efficacy of professional tooth whitening maintenance system of a Colgate toothpaste containing 5% Hydrogen Peroxide with a stain-fighter mouthwash as compared to only the stainfighter mouthwash and a negative control toothpaste
Primary Outcome
Changes in Tooth color determined by examiner use of Vita Extended Bleachedguide 3D-Master®(29 tabs)
Interventions
- OTHER whitening maintenance
- OTHER whitening maintenance MW
- OTHER negative control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2024-10-07 |
| Est. Completion | 2024-12-20 |
| Phase | NA |
What the finished NCT06613347 record still lists
NCT06613347 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 93 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which whitening maintenance is the first listed.
NCT06613347 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06613347 about?
NCT06613347 is a clinical study titled "Clinical Study to Assess the Efficacy of Professional Tooth Whitening Maintenance System". Clinical study to assess the efficacy of professional tooth whitening maintenance system of a Colgate toothpaste containing 5% Hydrogen Peroxide with a stain-fighter mouthwash as compared to only the stainfighter mouthwash and a negative control toothpaste
What is the current status of trial NCT06613347?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2024-10-07. Estimated completion is 2024-12-20.
What interventions are being tested in trial NCT06613347?
The interventions under investigation include: whitening maintenance (OTHER), whitening maintenance MW (OTHER), negative control (OTHER).
Who is sponsoring clinical trial NCT06613347?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06613347's enrollment target sits among peer trials
93 937th of 2000 higher than 1,064 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02203526 · 93 participants · Phase 1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- NCT03089554 · 93 participants · Phase 2
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- NCT05000021 · 93 participants · NA
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- NCT05489887 · 93 participants · Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI